Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs

Keyphrases

• 5-hydroxydecanoate 37%
• Acute Renal Failure 12%
• Anti-apoptotic 12%
• Antioxidant 12%
• Antioxidant System 12%
• Apoptosis 12%
• Apoptotic Markers 12%
• Apoptotic Mechanism 12%
• Beneficial Effects 12%
• Beta-blockers 12%
• Biopsy Specimen 12%
• Cell Survival 12%
• Channel Inhibitor 12%
• Custodiol 75%
• Inducible Nitric Oxide Synthase 12%
• Inflammatory Mechanisms 12%
• Intrarenal 12%
• Ischemia 12%
• Ischemia-reperfusion Injury 25%
• KATP Channel 12%
• Kidney Ischemia-reperfusion Injury 100%
• L-NAME 50%
• Levosimendan 100%
• Measure Function 12%
• Mitochondrial ATP 12%
• Mitochondrial KATP Channel 12%
• Multi-organ 12%
• N-acetylglucosaminidase 25%
• Nitric Oxide 12%
• Oxidative Processes 12%
• Peroxidation 12%
• Pig Model 12%
• Preservation Solution 12%
• Pro-survival 12%
• Protective Effect 12%
• Renal Artery 25%
• Renal Biopsy 12%
• Renal Function 25%
• Renal Ischemia-reperfusion Injury 25%
• Survival System 12%
• Tissue Peroxidation 12%

Pharmacology, Toxicology and Pharmaceutical Science

• 5 Hydroxydecanoic Acid 37%
• Acetic Acid Derivative 25%
• Acute Kidney Failure 12%
• Adenosine Triphosphate 25%
• Adenosine Triphosphate Sensitive Potassium Channel 12%
• Antiapoptotic 12%
• Antioxidant 25%
• Arginine Methyl Ester 12%
• Glucosaminidase 25%
• HTK Solution 75%
• Ischemia 25%
• Kidney Ischemia 100%
• Levosimendan 100%
• Nitric Oxide 12%
• Nitric Oxide Synthase 12%
• Porcine Model 12%
• Preservation Solution 12%
• Reperfusion Injury 100%
• Table Salt 12%